Op-ed by Prominent Community Leaders Highlights Severe Damage of New York’s Proposed Medicaid Carve-out

On March 23, an op-ed written by three prominent community leaders, Ms. Hazel Dukes, Rev Kirsten John Foy, and Rev Dr. Johnnie Green, was published in several outlets, including savenysafetynet.com and empirereportnetwork.com.  Their op-ed highlights the severe damage that will be inflicted on vulnerable communities resulting from the impending policy of the New York Department…

Bipartisan Group of Senators Reintroduce Bill to Protect Eligibility of 340B Hospitals During COVID-19 Pandemic

Last week, a bipartisan group of six senators, led by Senator John Thune (R-SD), reintroduced legislation (S. 773) that would allow disproportionate share hospital (DSH), children’s hospitals, and rural referral centers, or sole community hospitals to temporarily maintain 340B eligibility during the COVID-19 pandemic.  One of the requirements for these hospital types to participate in…

Indiana District Court Issues Order to Halt the 340B Administrative Dispute Resolution for Claims Against to Eli Lilly

On March 16, 2021, the U.S. District Court for the Southern District of Indiana issued an order granting Eli Lilly’s request for a preliminary injunction to halt the 340B Administrative Dispute Resolution Final Rule (ADR Rule).   The ADR Rule was issued to provide a binding and precedential way for 340B safety-net providers and manufacturers to…

HHS issues proposal to further delay the Trump Administration’s 340B insulin final rule

On March 9, 2021 the Department of Health and Human Services (HHS) issued a proposal to further delay implementation of the Trump Administration’s final rule that would require federally qualified health centers (FQHCs) to provide insulin and injectable epinephrine to low-income patients at the price the FQHC pays for those drugs under the 340B program. …

Express Scripts Issues 340B Claims Identification Requirements

Express Scripts, a large US-based PBM, announced a new 340B retrospective claims identification requirement.  The new policy may impose significant burdens on 340B pharmacies and threaten the viability of safety net providers. On February 24, Express Scripts, one of the largest pharmacy benefit managers (PBMs) in the United States, issued a notice stating that, beginning March 1, pharmacies…

PRESS STATEMENT: CV340B Names Advisory Council

  March 2, 2021 PRESS STATEMENT:  FOR IMMEDIATE RELEASE                                Contact:  Peggy.Tighe@PowersLaw.com CV340B Names Advisory Council – Prominent 340B Leaders Join National Efforts to Educate, Enable, and Inspire Support for the 340B Drug Pricing Program   Today, Community Voices for 340B (CV340B) announced the appointment of seven leaders who have long served safety net providers participating…

226 Members of Congress Sign Letter Condemning Manufacturer Actions

In a letter, led by Representatives Spanberger, Axne, Matsui, McKinley, sent to Acting HHS Secretary Norris Cochran, 226 Members of Congress called on HHS to take immediate action against manufacturers that refuse to provide discounted drugs to community safety net providers and require manufacturers to reimburse community safety net providers for overcharges. The also called on HHS…